EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection

Ling-Ling Wu, Qinxin Zhao, Qinghua Wang, Qingyang Zhang, Feiya Yang, Bo Zheng, Hai-Yu Hu, Nianzeng Xing

Acta Pharmaceutica Sinica B · 2023-03 · 13 (3) · 1204-1215

DOI: 10.1016/j.apsb.2022.07.018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-03. Verfasst von Ling-Ling Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Peking Union Medical College and Chinese …. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Meteorological Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluorescence-guided surgery (FGS) with tumor-targeted imaging agents, particularly those using the near-infrared wavelength, has emerged as a real-time technique to highlight the tumor location and margins during a surgical procedure. For accurate visualization of prostate cancer (PCa) boundary and lymphatic metastasis, we developed a new approach involving an efficient self-quenched near-infrared fluorescence probe, Cy-KUE-OA, with dual PCa-membrane affinity. Cy-KUE-OA specifically targeted the prostate-specific membrane antigen (PSMA), anchored into the phospholipids of the cell membrane of PCa cells and consequently showed a strong Cy7-de-quenching effect. This dual-membrane-targeting probe allowed us to detect PSMA-expressing PCa cells both in vitro and in vivo and enabled clear visualization of the tumor boundary during fluorescence-guided laparoscopic surgery in PCa mouse models. Furthermore, the high PCa preference of Cy-KUE-OA was confirmed on surgically resected patient specimens of healthy tissues, PCa, and lymph node metastases. Taken together, our results serve as a bridge between preclinical and clinical research in FGS of PCa and lay a solid foundation for further clinical research.

Schlagwörter

Stichwörter der Autor:innen

Activated probeDual-targetingFluorescence-guided surgeryMetastasesNear-infraredProstate cancerSelf-assemblySmall molecule nanoparticle

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.
  • Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, Chin…
  • Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
  • Department of Urology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China.

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Meteorological Sciences

Zitieren

APA

Wu, L. L., Zhao, Q., Wang, Q., Zhang, Q., Yang, F., Zheng, B., Hu, H. Y., & Xing, N. (2023). Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection. Acta Pharmaceutica Sinica B, 13(3), 1204-1215. https://doi.org/10.1016/j.apsb.2022.07.018

Vancouver

Wu LL, Zhao Q, Wang Q, Zhang Q, Yang F, Zheng B, et al. Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection. Acta Pharmaceutica Sinica B. 2023;13(3):1204-1215. doi:10.1016/j.apsb.2022.07.018

BibTeX
@article{Wu2023,
  author = {Wu, Ling-Ling and Zhao, Qinxin and Wang, Qinghua and Zhang, Qingyang and Yang, Feiya and Zheng, Bo and Hu, Hai-Yu and Xing, Nianzeng},
  title = {Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2023},
  volume = {13},
  number = {3},
  pages = {1204--1215},
  doi = {10.1016/j.apsb.2022.07.018}
}
Kostenlos starten →